TICKERNERD
Menu
METMETFinancial Services · Insurance - Life

MET Stock Forecast: MetLife, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$98
+0.19% on the day

The 18 Wall Street analysts covering MetLife, Inc. hold a median 12-month price target of $104 — +6.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 45 of 100 as at 15 Aug 2026 — in the lower half.

Market cap
$62.1B
Ticker Nerd rank
45 / 100
Median analyst target
$104
Analysts covering
18
Total return, dividends reinvested
1W
−0.1%
1M
+6.2%
YTD
+26.3%
1Y
+28.9%
From 52W high
−2.3%
From 52W low
+46.2%
$67
$100
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

MET stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores MetLife, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
45 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
81
Momentum
77
Revisions
75
Value
53
Growth
47
Volatility
42
Quality
34
Accruals
22
Size
5

Issuance (81): The share count has been shrinking and the company is not leaning on new borrowing.

Accruals (22): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (5): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

MET stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MET, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$60$70$80$90$100$110$120Oct 25Jan 26Apr 26Jul 26METHigh $119Median $104Low $84

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says18 analysts
12 Buy5 Hold1 Sell
Low $84Median $104High $119

The green dot is the last close — the median target sits +6.5% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 12 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
11 Aug 2026JP MorganMaintainsOverweight$106 → $108
11 Aug 2026Keefe, Bruyette & WoodsMaintainsOutperform$105 → $108
6 Aug 2026BarclaysMaintainsOverweight$94 → $97
22 July 2026TD CowenMaintainsBuy$87 → $105
22 July 2026TD CowenMaintainsBuy—
21 July 2026JP MorganMaintainsOverweight$96 → $106
21 July 2026JP MorganMaintainsOverweight—
13 July 2026Evercore ISI GroupMaintainsIn-Line—
13 July 2026Evercore ISI GroupMaintainsIn-Line$96 → $103
13 July 2026Keefe, Bruyette & WoodsMaintainsOutperform—
13 July 2026Keefe, Bruyette & WoodsMaintainsOutperform$98 → $105
10 July 2026JefferiesMaintainsBuy$97 → $103
10 July 2026JefferiesMaintainsBuy—
9 July 2026MizuhoMaintainsOutperform—
9 July 2026MizuhoMaintainsOutperform$95 → $102
9 July 2026Wells FargoMaintainsOverweight—
9 July 2026Wells FargoMaintainsOverweight$95 → $101
8 July 2026UBSMaintainsBuy$102 → $105
8 July 2026UBSMaintainsBuy—
7 July 2026BarclaysMaintainsOverweight$93 → $94

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MET appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

MET analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−1.2%
Analysts raising
5
Analysts cutting
9
Fundamentals

MetLife, Inc. (MET) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
18.7×

Cheaper than 41% of US stocks

Price / sales
0.8×

Cheaper than 75% of US stocks

Price / book
2.3×

Cheaper than 43% of US stocks

EV / EBITDA
14.2×

Cheaper than 26% of US stocks

Growth & margins
Revenue growth (YoY)
10.5%

Higher than 54% of US stocks

Earnings growth (YoY)
1.0%

Higher than 36% of US stocks

Gross margin
—
Operating margin
5.5%

Higher than 56% of US stocks

Net margin
4.6%

Higher than 59% of US stocks

Returns & dividend
Return on equity
13.1%

Higher than 71% of US stocks

Return on assets
0.5%

Higher than 45% of US stocks

Dividend yield
2.4%

Higher than 55% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

MET vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelInsurance - Life
CompanyMarket capTKN rank
METMetLife, Inc.$62.1B
45
AFLAflac, Inc.$63.7B
77
PRUPrudential Financial, Inc.$43.8B
74
UNMUnum Group$15.1B
51
GLGlobe Life, Inc.$14.4B
73
PRIPrimerica, Inc.$9.7B
84
JXNJackson Financial, Inc.$9.2B
65

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own MetLife, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest MET news & analysis

MetLife Q2 Earnings Call Highlights

MarketBeat · 8 Aug 2026positive

MetLife reported second-quarter 2026 adjusted earnings of approximately $1.6 billion, or $2.43 per share, up 15% from a year earlier. Adjusted EPS increased 20%, and adjusted return on equity reached 17%, the top end of the company's 15% to 17% annual target range.

Why it matters — The results show MetLife delivering earnings growth and hitting the top of its adjusted return-on-equity target range, which MET watchers would view as a strong performance indicator.

MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out

Seeking Alpha · 6 Aug 2026positive

Seeking Alpha reaffirmed a Buy rating on MetLife, Inc. following Q2 earnings, citing quality fundamentals, strong organic growth, and a resilient dividend profile. The piece notes MET's diversified business model drives organic growth across multiple segments, though modest profit margin expansion and fixed-income interest-rate risk warrant monitoring.

Why it matters — MET watchers would care because the report points to continued bullish momentum underpinned by organic growth and a durable dividend, while flagging interest-rate risk from fixed-income exposure.

MetLife Tops Q2 Earnings Estimates on Strong Investment Income

Zacks Investment Research · 6 Aug 2026positive

MetLife topped Q2 earnings per share estimates, driven by higher investment income, favorable underwriting, and business volume growth, which lifted earnings despite higher expenses. The results came in above analyst expectations for the period.

Why it matters — A MetLife watcher would care because the company's second-quarter earnings exceeded expectations, pointing to performance that was stronger than analysts had projected.

MetLife, Inc. (MET) Q2 2026 Earnings Call Transcript

Seeking Alpha · 6 Aug 2026neutral

Seeking Alpha published the transcript of MetLife, Inc.'s (MET) second-quarter 2026 earnings call. The item consists solely of the headline and excerpt announcing the availability of the Q2 2026 earnings call transcript.

Why it matters — A MET watcher would consult the transcript for management's discussion of the company's second-quarter 2026 financial results and outlook.

MetLife Pet Insurance Winner Of 2026 Pet Innovation Award For “Pet Insurance of the Year”

GlobeNewsWire · 6 Aug 2026positive

The 2026 Pet Innovation Awards announced that MetLife Pet Insurance is the recipient of its "Pet Insurance of the Year" award. The awards platform independently recognizes innovative companies, services, and products in the pet care industry.

Why it matters — The award is external recognition of MetLife's pet insurance offerings and their standing within the pet care industry.

FAQ

Frequently asked questions about MET stock

What is the MET stock price forecast for 2026-2027?

The 18 Wall Street analysts covering MetLife, Inc. have a median 12-month price target of $104, with estimates ranging from $84 to $119. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is MET stock a buy right now?

Of the 18 analysts covering MetLife, Inc., 12 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks MetLife, Inc. 45 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MET?

As at 15 Aug 2026, MetLife, Inc. ranks 45 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (81 of 100).

Will MET stock go up?

No one can know that. What the data says: the median 12-month target from 18 analysts implies +6.5% from the last close, and Ticker Nerd's factor model ranks MetLife, Inc. 45 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the MET stock forecast for 2030?

No analyst covering MetLife, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MET are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $84 to $119 over the next 12 months.

How has MET stock performed over the past year?

MetLife, Inc. returned +28.9% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does MetLife, Inc. do?

MetLife Inc. is a global financial services company that provides insurance, annuities, employee benefits, and asset management solutions to individual and institutional customers.

What is the latest news on MET?

The most recent item we track (MarketBeat, 8 Aug 2026): "MetLife Q2 Earnings Call Highlights". MetLife reported second-quarter 2026 adjusted earnings of approximately $1.6 billion, or $2.43 per share, up 15% from a year earlier. Adjusted EPS increased 20%, and adjusted return on equity reached 17%, the top end of the company's 15% to 17% annual target range.

Company

About MetLife, Inc.

MetLife Inc. is a global financial services company that provides insurance, annuities, employee benefits, and asset management solutions to individual and institutional customers. Its product range includes life insurance, retirement income products, group benefits, and workplace protection offerings such as dental, disability, and supplemental coverage. The company serves employers, organizations, and consumers through a broad portfolio designed to address protection, savings, and risk-management needs across different life stages. MetLife operates through major business segments spanning Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe, the Middle East and Africa, and MetLife Holdings, giving it exposure to multiple insurance and benefits markets worldwide. Headquartered in New York, MetLife remains a prominent participant in the global insurance industry through its diversified mix of protection and retirement-related services.

CEO Mr. Michel Abbas Khalaf · 46,000 employees · United States · https://www.metlife.com